SCHEMBL9542673

SCHEMBL9542673

C/C=C1\C[C@@H](C(=O)O)N(C(=O)OCc2ccccc2)C1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HTR2C P28335 1/20 0.45
PTPN1 P18031 1/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
PREP P48147 4/20 0.43
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9542681 1.00 SMN1; SMN2 (0.46) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL5765997 0.89 NPSR1 (0.46) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL5765999 0.89 NPSR1 (0.46) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL6649131 0.89 NPSR1 (0.46) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL6242346 0.86 SMN1; SMN2 (0.45) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL6242348 0.86 SMN1; SMN2 (0.45) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL11236406 0.84 NPSR1 (0.48) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL11236402 0.84 NPSR1 (0.48) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL14526634 0.83 PSEN1 (0.49) SMN1; SMN2NPSR1NPC1RAB9AHTR2C
SCHEMBL11237392 0.82 SMN1; SMN2 (0.44) SMN1; SMN2NPSR1NPC1RAB9APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993018045-A1 ANTI-CANCER PYRROLOBENZODIAZEPINE DERIVATIVES CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1993-09-16 WO disclosed